Sumant Kulkarni
Stock Analyst at Canaccord Genuity
(0)
# 4661
Out of 5,291 analysts
124
Total ratings
20.27%
Success rate
-19.26%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CervoMed | Maintains: Strong Buy | 12 21 | 9.26 | 126.78% | 5 | Mar 18, 2025 | |
Zevra Therapeutics | Maintains: Strong Buy | 23 25 | 7.83 | 219.28% | 6 | Mar 13, 2025 | |
Voyager Therapeutics | Maintains: Buy | 14 12 | 3.65 | 228.77% | 5 | Mar 13, 2025 | |
Compass Pathways | Maintains: Buy | 23 15 | 2.94 | 410.2% | 3 | Feb 28, 2025 | |
Biogen | Maintains: Buy | 298 265 | 138.4 | 91.47% | 15 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 9 8 | 8.27 | -3.26% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 73 | 6.72 | 986.31% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 172 163 | 113.11 | 44.11% | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 119 132 | 131.81 | 0.14% | 5 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 112 80 | 2.13 | 3655.87% | 7 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 28 | 11.04 | 153.62% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 11 | 1.47 | 648.3% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 83 | 3.25 | 2453.85% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 6.21 | 125.44% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 120 12 | 5.15 | 133.01% | 4 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 20 | 7.21 | 177.39% | 3 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 26 | 1.64 | 1485.37% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 33 | 17.06 | 93.43% | 13 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 2 | n/a | n/a | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 101 150 | 27.6 | 443.48% | 4 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 4 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 110 120 | n/a | n/a | 2 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 31, 2017 |